Delivery Order SPE2DB22D1002-SPE2DB25FKXF8
Award Date
1/28/25
Potential Completion Date
1/29/25
Potential Value
$1.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with ID SPE2DB22D3501|SPE2DB25FTP46, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,109.23, is for the delivery of Budesonide-Formoterol 80-4.5 10.2GM, a pharmaceutical product. The award has an ultimate completion date of November 22, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, with a unique identifier of SPE2DB20D2014|SPE2DB25FB19Q, was issued by the Defense Logistics Agency (DLA) to the prime contractor AmerisourceBergen Drug Corp. The contract is for the delivery of Budesonide-Formoterol 160-4.5 10.2GM, a pharmaceutical product, with a ceiling value of $2,955.84. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is set for February 28, 2025. The contract does not have a set-aside...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Budesonide-Formoterol 80-4.5 10.2GM medication. The contract has a firm fixed price structure and a not-to-exceed ceiling value of $2,118.68. The contract was awarded as a Delivery Order with an ultimate completion date of September 30, 2024. Amerisourcebergen, through its Corporate Office division, will supply this critical...
This federal contract award, with ID SPE2DB20D3111|SPE2DB25FA5XW, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Budesonide-Formoterol 160-4.5 10.2GM, a pharmaceutical product, with a firm fixed price ceiling value of $1,965.25 and a completion date of December 18, 2024. The contract is a delivery order, and is not designated as a set-aside. Amerisourcebergen...
This is a federal contract award issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,462.06, is for the delivery of budesonide-formoterol 80-4.5 10.2GM, a pharmaceutical product. This is a firm fixed-price delivery order contract with an ultimate completion date of October 18, 2023. The contract does not have a set-aside designation, indicating open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $1,030.05 firm fixed-price delivery order is for the pharmaceutical product Budesonide-Formoterol 80-4.5 10.2GM. The contract has an ultimate completion date of December 3, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider, and this award is part of the company's broader $999,999,999 Indefinite Delivery...
This federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Budesonide-Formoterol 160-4.5 10.2GM, a prescription medication. The contract has a ceiling value of $1,589.35 and is a firm fixed-price delivery order that runs until September 11, 2024. This contract award is not associated with a set-aside program. Amerisourcebergen, through its extensive supply chain capabilities,...
This federal contract award, valued at $1,372.04, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Budesonide-Formoterol 160-4.5 10.2GM, a pharmaceutical product, with a completion date of February 20, 2025. The contract is a Delivery Order under a Firm Fixed Price structure, and there was no set-aside designation used. AmerisourceBergen holds a significant...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,094.97, is a delivery order for the supply of budesonide-formoterol 160-4.5 10.2GM, a pharmaceutical product. The contract has an ultimate completion date of December 3, 2024 and a firm fixed price pricing structure. AmerisourceBergen Drug Corp is the prime contractor, and there is no set-aside...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $20,760.00, is a delivery order for the supply of Budesonide-Formoterol 160-4.5 10.2GM, a pharmaceutical product. The contract has an ultimate completion date of March 10, 2025 and is a firm fixed-price arrangement. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...